Comments
Shares of Sanofi India surged over 5 per cent in morning trade on the bourses after the drug firm reported over two—fold increase in its net profit at ₹ 92.7 crore for the fourth quarter ended December 31, 2013.
Reacting to the good numbers, shares of the company opened on a bullish note and jumped 5.25 per cent to an intra—day high of ₹ 2,779 on the BSE.
Similar movement was seen on the National Stock Exchange as well where the stock after opening at ₹2,730, jumped 5.60 per cent to an early high of ₹ 2,780.
Sanofi India’s net profit for the quarter ended December 31, 2013, witnessed over two—fold increase on account of robust sales in the export markets. The company had posted a net profit of ₹ 44.8 crore during the same period for the previous fiscal.
“Sanofi India posted numbers better than expected”, Angel Broking (VP—Research, Pharma) Sarabjit Kour Nangra said adding that the main surprise came in at operating front.
The company while announcing the earnings yesterday, said that the significantly better export performance during the quarter and the year ended December 31, 2013, has resulted in improvement in profitability of the company.
Moreover, the company’s board has recommended final dividend of ₹ 35 per equity share of ₹ 10 for the year ended December 31, 2013.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.